Products

Products

Our Portfolio

Therapeutic Areas

Nordic Pharma has a range of proprietary and in-licensed products in the following therapeutic areas: Women’s Health, Rheumatology, Critical Care.

nordic-pharma-portfolio-of-therapeutic-areas-rheumatology

Rheumatology

Nordimet® Pre-Filled Syringe (PFS)

Nordimet® / iMETH® / Zlatal® Pre-Filled Syringe

Nordimet® is a pre-filled syringe containing a solution of methotrexate.
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents, other immunosuppressants.
Methotrexate is a folic acid antagonist which belongs to the class of cytotoxic agents known as antimetabolites. It acts by the competitive inhibition of the enzyme dihydrofolate reductase and thus inhibits DNA synthesis.*

*SmPC
For more information, click here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Nordimet® Auto-Injector (AI)

Nordimet® Auto-Injector

Nordimet® pen is an auto-injector containing a solution of methotrexate.
Pharmacotherapeutic group: Immunosuppressants, other immunosuppressants. ATC code: L04AX03.
Methotrexate is a folic acid antagonist which belongs to the class of cytotoxic agents known as antimetabolites. It acts by the competitive inhibition of the enzyme dihydrofolate reductase and thus inhibits DNA synthesis.*

*SmPC
For more information, click here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Women’s Health

Mifegyne®

Mifegyne®

Mifegyne® is a mifepristone drug.
Pharmacotherapeutic group: Other Sex Hormone and Modulator of the Reproductive function/Antiprogestogen
Mifepristone has an antiprogestin activity by acting as a competitive antagonist of the progesterone at the receptor level. It helps to increase myometrial contractility and to soften the cervix.*

*SmPC, which can be found here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

MisoOne®

MisoOne® / Topogyne® / Mispregnol®

MisoOne® is a misoprostol drug.
Pharmacotherapeutic class: Other gynaecological drugs, oxytocics – prostaglandins
Misoprostol is a prostaglandin analogue that triggers uterine contractions and relaxation of the cervix.*

*SmPC, which can be found here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Hyalobarrier®

Hyalobarrier® Gel / Hyalobarrier® Gel Endo

Hyalobarrier® Gel and Hyalobarrier® Gel Endo are transparent and highly viscous gels made of 4% and 3% of auto-crosslinked polymer of hyaluronic acid, respectively, and provided in sterile single-use, pre-filled 10 mL syringes.
Hyalobarrier® is applied at the end of a surgery to the tissue surface and to the abdominal wall, creating an anti-adhesion barrier which keeps the adjacent tissues separated during the repair phase subsequent to a surgical procedure. It is a Class III medical device.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the instruction for use (IFU). For advice on medical issues please consult your local medical practitioner.

checkToP®

checkToP®

checkToP® is an immunochromatographic low-sensitivity (1000 mIU/mL) urinary rapid test for the semi-quantitative detection of β-hCG (human chorionic gonadotropin) level in urine for home use. It is a Class I medical device.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the instruction for use (IFU). For advice on medical issues please consult your local medical practitioner.

nordic-pharma-portfolio-of-therapeutic-areas-womens-health
nordic-pharma-portfolio-of-therapeutic-areas-critical-care

Critical Care

Trasylol®

Trasylol®

Trasylol® is an aprotinin solution.
Pharmacotherapeutic group: Antihemorrhagics, proteinase inhibitors
Aprotinin is a broad-spectrum protease inhibitor which has antifibrinolytic properties. This means that it stops the body breaking down blood clots.*
It is for adult use only.**

*https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-lifting-suspension-aprotinin
**SmPC, which can be found here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Teysuno®

Teysuno®

Teysuno® (tegafur/gimeracil/oteracil) is a fluoropyrimidine anti-cancer medicinal product.
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites
It is a fixed dose combination of three active substances, tegafur, which after absorption is converted into the anti-cancer substance 5-FU; gimeracil, a dihydropyrimidine dehydrogenase (DPD) inhibitor to prevent degradation of 5-FU by the body; and, oteracil, an orotate phosphoribosyltransferase (OPRT) inhibitor that decreases the activity of 5-FU in normal gastrointestinal mucosa.
Teysuno should only be prescribed by a doctor who is experienced in the use of cancer medicines.*
It is known in Asia as S-1.

*SmPC, which can be found here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Amglidia®

Amglidia®

Amglidia® is a glibenclamide oral suspension adapted to children.
Pharmacotherapeutic group: Drugs used in diabetes, sulphonylureas.
Sulphonylureas will act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels.
The mechanisms of action proposed for this effect include stimulation of insulin release by beta-cells of the pancreas.*

*SmPC, which can be found here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Others

OTC Line Scandinavia

OTC Line Scandinavia

The OTC portfolio focuses on the gastrointestinal and common cold therapeutic areas. The portfolio consists of several well-known and market-leading brands, local as well as international. Nordic Pharma commercializes this range in Northern Europe.

More information here

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

Generics Line Scandinavia & CEE Region

Generics Line Scandinavia & CEE Region

The generic products represent a diversified portfolio in various therapeutic areas, namely oncology, pain relief and respiratory. Nordic Pharma commercializes this range mainly in Northern Europe and in the Central-Eastern European region.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.

nordic-pharma-portfolio-of-therapeutic-areas-others

About Our Values